छोड़कर सामग्री पर जाएँ

Cipla stock gains; US FDA inspection concludes with zero observations

Cipla has completed the transfer of its generics business #39;as a going concern on a slump sale basis to Cipla Pharma and Life Sciences Limited#39;, the company told bourses

Read More

​ Cipla has completed the transfer of its generics business #39;as a going concern on a slump sale basis to Cipla Pharma and Life Sciences Limited#39;, the company told bourses Cipla has completed the transfer of its generics business #39;as a going concern on a slump sale basis to Cipla Pharma and Life Sciences Limited#39;, the company told bourses  Moneycontrol Latest News Read More  

प्रातिक्रिया दे

आपका ईमेल पता प्रकाशित नहीं किया जाएगा. आवश्यक फ़ील्ड चिह्नित हैं *

hi_INहिन्दी